Logo - International Journal of Pharmaceutical Compounding

Minimizing the Risk of Cholesterol-Lowering Therapy

Author(s):  Pratt Sam

Issue:  Sep/Oct 2001 - Bioidentical Hormone Replacement Therapy
View All Articles in Issue

Abstract:  The author discusses statins, which work by blocking the production of cholesterol at the mevalonate pathway, from the perspective that they can create new problems for the heart patient. Main topics of discussion are statin use and heart disease and additional benefits of Coenzyme Q10 therapy; two case reports are also presented, illustrating the beneficial effects of Coenzyme Q10 and negative effects of Mevacor on Coenzyme Q10 levels.

Related Keywords: Coenzyme Q10, cardiac disease, treatment of, Statins, cardiac disease, treatment of

Related Categories: SUPPORT

Purchase this article for download in electronic PDF format from IJPC at for $35 at:
http://www.ijpc.com/Products/ProductAddToCart.cfm?PID=1398

Search the entire IJPC archive by keyword, topic, or issue at:
http://ijpc.com/Products